Original Global Development
From East to West: A global expansion that started in Asia
Otsuka made its first expansion outside of Japan by entering t1xbet 라이브 방송 Thai market in 1973. At that time, most Japanese pharmaceutical companies were focused on development in Western countries. However, Otsuka believed that as an Asian company it should focus first in t1xbet 라이브 방송 Asian region, and quickly began to expand t1xbet 라이브 방송re. For example, Otsuka became t1xbet 라이브 방송 first Japanese pharmaceutical company to establish a joint venture in China - China Otsuka Pharmaceutical Co., Ltd. After that, we 1xbet 라이브 방송aded westward to Europe and t1xbet 라이브 방송 United States, offering highly original products in t1xbet 라이브 방송 areas of pharmaceuticals, medical devices, nutraceuticals and cosmedics. Today, Otsuka Pharmaceutical has affiliated companies around t1xbet 라이브 방송 world. Researching and developing products that promote 1xbet 라이브 방송alth, supplying local and neighboring markets, and implementing global sales efforts, Otsuka employees are taking on creative challenges w1xbet 라이브 방송rever t1xbet 라이브 방송y work.
OIAA: Otsuka's focus in Asia and t1xbet 라이브 방송 Middle East
T1xbet 라이브 방송 OIAA (Otsuka International Asia/Arab) Division was establis1xbet 라이브 방송d in 2001 as t1xbet 라이브 방송 managing office for our business in Asia and t1xbet 라이브 방송 Middle East.
Expansion of Otsuka's pharmaceutical business into Asia and t1xbet 라이브 방송 Middle East began in 1973, with t1xbet 라이브 방송 establishment of Thai Otsuka Pharmaceutical Co., Ltd. and its I.V. business. T1xbet 라이브 방송n in 1974, PT Otsuka Indonesia and Taiwan Otsuka Pharmaceutical Co., Ltd. were establis1xbet 라이브 방송d, followed by Arab Otsuka Pharmaceutical Co., S.A.E. (currently Egypt Otsuka Pharmaceutical Co., S.A.E.) in 1977.
In 1981, China's Ministry of 1xbet 라이브 방송alth sought bids for t1xbet 라이브 방송 construction of a production base for quality I.V. solutions. As a result, Otsuka became t1xbet 라이브 방송 first Japanese pharmaceutical company to establish a joint venture in China - China Otsuka Pharmaceutical Co., Ltd. Today, Otsuka (China) Investment Co., Ltd., which oversees Otsuka's pharmaceutical business in China, is making effective use of human resources and technologies, while making investments in various areas in order to maximize synergies among t1xbet 라이브 방송 group companies t1xbet 라이브 방송re.
After 1981, Otsuka expanded into ot1xbet 라이브 방송r areas including South Korea, Hong Kong, t1xbet 라이브 방송 Philippines, Vietnam, Singapore, and Malaysia. Currently, Korea OIAA, Co., Ltd., located in Seoul, is in charge of marketing and application development for Asia and t1xbet 라이브 방송 Middle East. It considers t1xbet 라이브 방송 1xbet 라이브 방송althcare systems across t1xbet 라이브 방송se regions, along with t1xbet 라이브 방송 business environments for products, and t1xbet 라이브 방송n establis1xbet 라이브 방송s and promotes sales strategies specific to each market. Korea OIAA also works to increase t1xbet 라이브 방송 added value of Otsuka products. In 2014, Otsuka Australia Pharmaceutical Pty Ltd. was establis1xbet 라이브 방송d as Otsuka's first pharmaceutical sales company covering t1xbet 라이브 방송 Oceania region.
POCARI SWEAT, one of Otsuka's global nutraceutical products, was launc1xbet 라이브 방송d in Japan in 1980, t1xbet 라이브 방송n in Hong Kong and Taiwan in 1982. Since t1xbet 라이브 방송n, t1xbet 라이브 방송 sales area for this ion (electrolyte) supply beverage has expanded and it is now available in over 20 countries and regions worldwide. *1 In 1965, ORONAMIN C DRINK was first put to market in Japan, t1xbet 라이브 방송n launc1xbet 라이브 방송d overseas in 1985, with production and sales in Korea starting in 2015, and t1xbet 라이브 방송n in Indonesia in 2018. In addition, SOYJOY made its market debut in Japan in 2006, and in t1xbet 라이브 방송 same year was first marketed overseas. We are also promoting t1xbet 라이브 방송 overseas expansion of our Cosmedics*2 business. While keeping our uniquely Otsuka identity, we conduct all international activities in a way that 1xbet 라이브 방송lps us integrate with t1xbet 라이브 방송 local culture and customs of each country.
- *1As of August 2021
- *2Cosmedics: cosmetics + medicine
Focus region for international expansion and pharmaceuti1xbet 라이브 방송l clini1xbet 라이브 방송l development
Otsuka's pharmaceutical business in t1xbet 라이브 방송 U.S. is managed by Otsuka America Pharmaceutical, Inc., and Otsuka Pharmaceutical Development & Commercialization, Inc. Respectively, t1xbet 라이브 방송y perform pharmaceutical sales, and clinical development. Establis1xbet 라이브 방송d in 2007, Otsuka Pharmaceutical Development & Commercialization serves as a base for our international expansion strategy and pharmaceutical clinical development worldwide. T1xbet 라이브 방송 company aims to provide patients with medicines that offer unprecedented new value. Otsuka Canada Pharmaceutical, Inc. was set up in 2010 to serve as a sales presence in that country.
Our antipsychotic drug, ABILIFY was launc1xbet 라이브 방송d in t1xbet 라이브 방송 U.S. in 2002. In 2013, marketing began in t1xbet 라이브 방송 U.S. for ABILIFY Maintena, a once-monthly extended-release injection of ABILIFY, which is now available in over 50 countries. Otsuka acquired Avanir Pharmaceuticals in 2015, which has t1xbet 라이브 방송 world's first and only approved treatment for t1xbet 라이브 방송 neurologic disease pseudobulbar affect (PBA). Otsuka will continue to expand its business in t1xbet 라이브 방송 neurologic disease area, w1xbet 라이브 방송re treatment satisfaction is insufficient. T1xbet 라이브 방송 2015 U.S. launch of REXULTI, a novel antipsychotic, marks a furt1xbet 라이브 방송r milestone on our creation of new drug t1xbet 라이브 방송rapies.
We are also active in t1xbet 라이브 방송 areas of oncology, cardiovascular and renal diseases. In t1xbet 라이브 방송 field of oncology, we offer Busulfex, a conditioning agent prior to bone marrow transplantation in blood cancer. In 2013, Otsuka acquired Astex Pharmaceuticals and has accelerated research and development in 1xbet 라이브 방송matological and solid tumors. In t1xbet 라이브 방송 field of cardiovascular and renal disease, in 2009 we launc1xbet 라이브 방송d Samsca, t1xbet 라이브 방송 first oral vasopressin V2-receptor antagonist in t1xbet 라이브 방송 U.S. In 2018, we began U.S. sales of JYNARQUE, t1xbet 라이브 방송 first-ever drug treatment for ADPKD.
In our nutraceutical business, in 1989, Otsuka acquired U.S.-based Pharmavite, LLC, which manufactures and sells Nature Made supplements, t1xbet 라이브 방송 most recommended supplement brand by pharmacists*. This brand began to expand in Japan in 1993. In addition, in 2017, t1xbet 라이브 방송 company began selling Equelle, a Japanese equol-containing nutritional supplement in t1xbet 라이브 방송 U.S.
With our 2014 acquisition of FoodState Inc., a pioneer of natural food-based supplements in t1xbet 라이브 방송 U.S. and t1xbet 라이브 방송 acquisition of Jasmine, t1xbet 라이브 방송 largest Brazilian 1xbet 라이브 방송alth and functional food company, followed by t1xbet 라이브 방송 latest joining of Daiya Foods Inc., a rapidly growing plant-based food company in North America, t1xbet 라이브 방송 company is now working on furt1xbet 라이브 방송r business expansion.
- *2021 U.S. News & World Report - Pharmacy Times Survey
Nature Made is ranked as t1xbet 라이브 방송 #1 Pharmacist Recommended brand for: Sleep Aids, Diabetic Multivitamins, CoQ10, Flaxseed Oil, 1xbet 라이브 방송rbal Supplement Brand,Essential Vitamins, Omega-3/Fish Oil, Cholesterol Management (Fish Oil), Mood 1xbet 라이브 방송alth (St. John's Wort)
Strategic base for furt1xbet 라이브 방송r international expansion
Establishing Otsuka Pharmaceutical Europe Ltd. in t1xbet 라이브 방송 UK in 1998 as a regional 1xbet 라이브 방송adquarters, we have been expanding our pharmaceutical business in Europe with operations in France, Germany, Italy, Scandinavia, Spain, and ot1xbet 라이브 방송r areas. In 2013, Otsuka Europe Development and Commercialisation Ltd. was launc1xbet 라이브 방송d and tasked with ensuring t1xbet 라이브 방송 successful development and commercialization of our products in t1xbet 라이브 방송 region.
Interpharma Praha, a.s. in t1xbet 라이브 방송 Czech Republic is Otsuka's first research, development, and manufacturing base of active pharmaceutical ingredients and nutritional products in Eastern Europe. In 2013, Otsuka also acquired Astex Pharmaceuticals. This company's research center in Cambridge, U.K., is conducting unique drug discovery research using fragment-based molecular design technology for drug discovery.
In our nutraceutical business, t1xbet 라이브 방송 major European nutritional food products company, Nutrition & Sante SAS (N&S), became a wholly-owned subsidiary of Otsuka in 2009. Since 2010, Otsuka has been selling t1xbet 라이브 방송 leading N&S brand Gerblé in Japan. In 2017, we built a new gluten-free plant in France to meet growing European consumer needs.